PROTHERICS
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

PROTHERICS Trademark

Serial Number: 97154933

PROTHERICS is a trademark filed by Protherics Medicines Development Limited on December 3, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Protherics Medicines Development Limited (20 trademarks)

London EC4M7RD , GB

Entity Type: 11

Trademark Details

Filing Date

December 3, 2021

Registration Date

Not Registered

Published for Opposition

May 9, 2023

Goods & Services

Pharmaceutical preparations for the treatment of snake bite venom; Pharmaceutical preparations for the treatment of digoxin toxicity and/or overdose; Pharmaceutical preparations for the treatment of methotrexate toxicity and/or overdose; Pharmaceutical preparations, including potassium iodide, for the treatment of exposure to nuclear radiation; Pharmaceutical preparations for the treatment of cyanide poisoning

Financial planning and investment banking services; monetary affairs, namely financial information, management and analysis services; Banking; Financial management; Financial analysis; Financial evaluation; Financial consultancy; Mutual funds and capital investments; Fund investment services; Financing services for companies

Business management consultancy and advisory services, namely, Business management and organization consultancy; Business auditing; Business project management services; Analysis of market research data; Consultancy relating to tax accounting; Business management consultancy services

Chemical reagents for non-medical purposes; Reagents for chemical analyses other than for medical or veterinary purposes; Active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of snake bite venom, the treatment of digoxin toxicity and/or overdose, the treatment of methotrexate toxicity and/or overdose, the treatment of exposure to nuclear radiation and the treatment of cyanide poisoning

Provision of medical services

Surgical apparatus and instruments; Medical devices for use in surgery, emergency care or in the treatment of epilepsy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 5, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 5, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 5, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 3, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 3, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 3, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 4, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 9, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 9, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 19, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 10, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 10, 2023 REAP
ASSIGNED TO EXAMINER
Feb 13, 2023 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 13, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 13, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 13, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 13, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2021 NWOS
NEW APPLICATION ENTERED
Dec 7, 2021 NWAP